Wang YD - Search Results

1

Development of erythrina-based PARP-1/FTase dual-target inhibitors against lung cancer epithelial-mesenchymal transition (EMT) in vivo and in vitro.

Yu L, Wang YD, Yan ZW, Zhang LY, Li S. Yu L, et al. Among authors: wang yd. Bioorg Chem. 2024 Jul;148:107480. doi: 10.1016/j.bioorg.2024.107480. Epub 2024 May 19. Bioorg Chem. 2024. PMID: 38772291

2

Novel Liver-targeted conjugates of Glycogen Phosphorylase Inhibitor PSN-357 for the Treatment of Diabetes: Design, Synthesis, Pharmacokinetic and Pharmacological Evaluations.

Zhang L, Song C, Miao G, Zhao L, Yan Z, Li J, Wang Y. Zhang L, et al. Sci Rep. 2017 Feb 22;7:42251. doi: 10.1038/srep42251. Sci Rep. 2017. PMID: 28225016 Free PMC article.

3

Design, Synthesis, and Use of Novel Photoaffinity Probes in Measuring the Serum Concentration of Glycogen Phosphorylase.

Zhang Y, Wang Y, Yan Z, Song C, Miao G, Zhang L. Zhang Y, et al. Molecules. 2019 Feb 22;24(4):798. doi: 10.3390/molecules24040798. Molecules. 2019. PMID: 30813328 Free PMC article.

4

Design, Synthesis, and Biological Application of Novel Photoaffinity Probes of Dihydropyridine Derivatives, BAY R3401.

Zhang L, Yan Z, Wang Y, Song C, Miao G. Zhang L, et al. Molecules. 2019 Jun 28;24(13):2394. doi: 10.3390/molecules24132394. Molecules. 2019. PMID: 31261804 Free PMC article.

5

Synthesis, in vitro ADME profiling and in vivo pharmacological evaluation of novel glycogen phosphorylase inhibitors.

Miao GX, Wang YD, Yan ZW, Zhang LY. Miao GX, et al. Among authors: wang yd. Bioorg Med Chem Lett. 2020 Jul 15;30(14):127117. doi: 10.1016/j.bmcl.2020.127117. Epub 2020 Mar 20. Bioorg Med Chem Lett. 2020. PMID: 32527535

6

Discovery and evaluation of novel benzazepinone derivatives as glycogen phosphorylase inhibitors with potent activity.

Wang Y, Yan Z, Guo Y, Zhang L. Wang Y, et al. Future Med Chem. 2021 May;13(10):897-909. doi: 10.4155/fmc-2020-0352. Epub 2021 Apr 28. Future Med Chem. 2021. PMID: 33906369

7

Long-term pharmacokinetic and pharmacological evaluations of a novel indole-benzazepinone derivative on obese Type 2 diabetes mellitus.

Wang Y, Li S, Yan Z, Guo Y, Yang D, Zhang L. Wang Y, et al. Future Med Chem. 2022 Nov;14(21):1495-1506. doi: 10.4155/fmc-2022-0115. Epub 2022 Sep 15. Future Med Chem. 2022. PMID: 36106605

8

Discovery of novel heterocyclic derivatives as potential glycogen phosphorylase inhibitors with a cardioprotective effect.

Yan Z, Li S, Wang Y, Li J, Ma C, Guo Y, Zhang L. Yan Z, et al. Bioorg Chem. 2022 Dec;129:106120. doi: 10.1016/j.bioorg.2022.106120. Epub 2022 Sep 3. Bioorg Chem. 2022. PMID: 36108587

9

A Novel 5-Chloro-N-phenyl-1H-indole-2-carboxamide Derivative as Brain-Type Glycogen Phosphorylase Inhibitor: Potential Therapeutic Effect on Cerebral Ischemia.

Huang Y, Li S, Wang Y, Yan Z, Guo Y, Zhang L. Huang Y, et al. Molecules. 2022 Sep 26;27(19):6333. doi: 10.3390/molecules27196333. Molecules. 2022. PMID: 36234871 Free PMC article.

10

A Novel 5-Chloro-N-phenyl-1H-indole-2-carboxamide Derivative as Brain-Type Glycogen Phosphorylase Inhibitor: Validation of Target PYGB.

Huang Y, Li S, Wang Y, Yan Z, Guo Y, Zhang L. Huang Y, et al. Molecules. 2023 Feb 10;28(4):1697. doi: 10.3390/molecules28041697. Molecules. 2023. PMID: 36838691 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,122 results

Search Page

Filters